

In this work we synthesized new monofunctional gold(III) complex [Au(Cl-Ph-tpy)Cl]Cl2 (Cl-Ph-tpy = 4′-[4-chlorophenyl]-2,2′:6′, 2″-terpyridine). This complex was characterized by UV–Vis, NMR, IR, and ESI-MS spectrometry. The kinetic study of the substitution reactions of the Au-Cl-Ph-tpy complex with biomolecules showed that the rate constants depend on the nature of the entering nucleophile. Based on the calculated values of entropy (∆H≠ > 0) and enthalpy (∆S≠ < 0) the proposed substitution mechanism is associative. Additionally, the relative stability and thermodynamic properties of Au-Cl-Ph-tpy complex were compared with the analogue Au-tpy complex by the B3LYP/def2-svp method. DNA/BSA binding studies showed that Au-Cl-Ph-tpy complex interacts with CT DNA through the intercalation and moderately quenches the fluorescence of tryptophan residues in serum albumin (BSA). Molecular docking confirmed results obtained by spectroscopic experiments and suggested site I (subdomain IIA) for binding of Au complex to BSA. We demonstrated that the Au chlorophenyl terpyridine complex possessed significant in vitro cytotoxic activity against human oral squamous carcinoma cells (CAL-27), induced apoptosis, inhibited proliferation of CAL-27 cells, and induced cell cycle disturbance. Treatment of CAL-27 cells with the Au complex enhanced expression of cyclin-dependent kinase inhibitors p21 and p27, resulting in cell cycle arrest in the G1 phase, reduced the percentage of CAL-27 cells in S phase and decreased expression of Ki-67. Additionally, Au complex reduced expression of phosphorylated STAT3 and downstream regulated molecules associated with cancer stemness, NANOG, and Sox2 protein. © 2022 John Wiley & Sons Ltd.
| Engineering controlled terms: | Amino acidsBiomoleculesDiseasesGold compoundsRate constantsSubstitution reactionsThermodynamic properties |
|---|---|
| Engineering uncontrolled terms | Anticancer activitiesAu-complexesBio-molecularBiomolecular interactionsCancer stemnessDocking simulationsGold(III) complexInteraction activitiesOral squamous cell carcinomataTerpyridines |
| Engineering main heading: | Cell death |
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| JP 1919,JP18/19,MP 0219 | ||
| Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja | 062018,451‐03‐68/2022‐14/200122,451‐03‐68/2022‐14/200378,ON175069 | MPNTR |
| Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja | MPNTR | |
| Childhood Cancer Canada | CCC |
The authors are grateful to the Ministry of Education, Science and Technological Development of the Republic of Serbia (Agreement No. 451‐03‐68/2022‐14/200378, Agreement No. 451‐03‐68/2022‐14/200122 and ON175069), the bilateral project with PR China (062018), and the Faculty of Medical Sciences of the University of Kragujevac, Serbia (MP 0219 and JP18/19, JP 1919) for financial support. D.Ć. would like to thank Prof. Tim Clark and Prof. Petra Imhof for hosting this work at the CCC. D.Ć. gratefully acknowledge the Regionales Rechenzentrum Erlangen (RRZE) for a generous allotment of computer time. / / /
The authors are grateful to the Ministry of Education, Science and Technological Development of the Republic of Serbia (Agreement No. 451-03-68/2022-14/200378, Agreement No. 451-03-68/2022-14/200122 and ON175069), the bilateral project with PR China (06/2018), and the Faculty of Medical Sciences of the University of Kragujevac, Serbia (MP 02/19 and JP18/19, JP 19/19) for financial support. D.Ć. would like to thank Prof. Tim Clark and Prof. Petra Imhof for hosting this work at the CCC. D.Ć. gratefully acknowledge the Regionales Rechenzentrum Erlangen (RRZE) for a generous allotment of computer time.
Kesić, A.; University of Kragujevac, Institute for Information Technologies Kragujevac, Department of Natural Sciences, Jovana Cvijića bb, Kragujevac, Serbia;
Simović, A.R.; University of Kragujevac, Institute for Information Technologies Kragujevac, Department of Natural Sciences, Jovana Cvijića bb, Kragujevac, Serbia;
© Copyright 2023 Elsevier B.V., All rights reserved.